Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Amiodarone pulmonary toxicity.

Philippe Camus¹, William J Martin, Edward C Rosenow

¹Department of Pulmonary Medicine and Critical Care, Centre Hospitalier et Université de Bourgogne, F-2100 Dijon, France. phillipe.camus@chu-dijon.fr

Clinics in Chest Medicine

|April 6, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.

ERJ open research·2026

Same author

Honoring 25 Years of the ATS Public Advisory Roundtable: Advancing Science Through the Patient Voice.

American journal of respiratory and critical care medicine·2026

Same author

CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever.

Nature communications·2026

Same author

Mapping the developmental path for Parkinson's disease therapeutics.

NPJ Parkinson's disease·2025

Same author

Using the grip strength effort task to measure reward processing dysfunction in schizophrenia and major depressive disorder.

Neuroscience applied·2025

Same author

Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials.

Schizophrenia bulletin·2025

Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026

Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026

Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026

Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026

Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026

Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026

See all related articles

Amiodarone pulmonary toxicity (APT) literature peaked decades ago but has resurged, indicating it remains a significant clinical issue. Early diagnosis and management of APT are crucial for patient outcomes.

Area of Science:

Cardiology
Pulmonology
Pharmacology

Background:

Amiodarone pulmonary toxicity (APT) is a serious adverse effect of amiodarone therapy.
Literature on APT peaked in the mid-1980s, with a subsequent decline, but has increased since the mid-1990s.
This resurgence suggests APT remains a relevant clinical challenge.

Purpose of the Study:

To highlight the persistent clinical relevance of amiodarone pulmonary toxicity.
To underscore the diagnostic challenges associated with APT.
To emphasize the variable outcomes in managing APT.

Main Methods:

Literature review and analysis of publication trends related to amiodarone pulmonary toxicity.
Synthesis of reported clinical cases and outcomes.

Related Experiment Videos

Discussion of diagnostic difficulties and treatment efficacy.

Main Results:

A significant peak in APT literature occurred in 1983-1984.
Post-1990s publications indicate a renewed increase in reported APT cases.
Noninvasive diagnosis of APT remains challenging.
While many patients achieve good outcomes, some APT cases are refractory to treatment.

Conclusions:

Amiodarone pulmonary toxicity continues to be an important clinical concern.
Improved diagnostic strategies and management protocols for APT are needed.
Ongoing vigilance and research are essential for optimizing patient care regarding amiodarone use.